Explore our specialized active ingredient screening modules, bioassay platforms, and analytical method qualification pipelines designed for immediate integration into your international R&D pipeline.
High-throughput isolation and bio-guided fractionating of alkaloids, saponins, flavonoids, and terpenes tailored to specific pharmacological targets.
View Service Specifications
Targeted animal disease models, metabolic pathway tracing, sub-chronic toxicity assays, and pharmacokinetics (PK/PD) profiling.
Explore Study Protocols
Primary cell cultures, enzyme kinetics inhibition (COX-2, ACE, alpha-glucosidase), receptor binding, and cellular antioxidant protection indexes.
Examine In Vitro Assays
ICH-GCP compliant human efficacy studies, dietary supplement pilot trials, and registration data packages supporting NDA filings.
View Clinical Trial Models
Comparative metabolomic mapping of raw botanicals across harvest windows, altitudes, and geographical origins to guarantee peak active density.
Request Origin Analysis
Custom HPLC, GC, LC-MS/MS, and HPTLC fingerprint qualification to define rigorous batch-release specifications and pharmacopeial compliance.
View Analytical Protocols
Multiplexed molecular target assaying identifying lead plant molecules with verified therapeutic efficacy, minimal toxicity, and commercial viability.
Discover Bioactive Screening
Systematic chemometric profiling of medicinal raw materials to determine ideal plant anatomy, harvest phases, and optimal drying technologies.
Review Evaluation DatasetsNavigating the intersection of multi-target natural pharmacology, high-resolution metabolomics, and industrial-scale contract manufacturing.
For decades, commercial natural products were impeded by raw material variability, unknown mechanism of actions (MoA), and unpredictable clinical outcomes. Modern active ingredient screening reverses this paradigm by applying target-directed phenotypic profiling, identifying distinct chemical entities (such as specific monomeric saponins, sesquiterpene lactones, or polyphenolic glycosides) responsible for physiological endpoints, converting empirical herbal remedies into scientifically defended actives.
The emergence of algorithmic target prediction, virtual molecular docking against crystallographic receptor libraries, and automated liquid handling has condensed compound discovery timeframes by over 70%. At MedGence (Yineng Pharma), screening blends computational prediction with empirical in vitro validation, rapidly prioritizing fractions exhibiting the highest affinity, metabolic stability, and biological membrane permeability before initiating pilot synthesis.
Global health authorities—including the US FDA (Botanical Drug Guidance), the European Medicines Agency (HMPC Herbal Monographs), and the NMPA—demand comprehensive phytochemical identification and chromatographic fingerprints. We establish chemical assay baselines right from early discovery, guaranteeing full alignment with European Pharmacopoeia (EP), United States Pharmacopeia (USP), and Chinese Pharmacopoeia (ChP) standards.
Mitigating supply disruptions, chemical adulteration, and analytical ambiguity across the multi-billion dollar nutraceutical, functional cosmetic, and phytomedicine ecosystems.
Procurement officers consistently cite inconsistent active content as their number one operational vulnerability. Variations in sunlight, soil microflora, and drying methods create active ingredient oscillations of up to 400% in non-standardized raw crops. Our multi-origin agronomic screening maps quantitative metabolite ranges, establishing standardized extract protocols that guarantee consistent active markers across 100% of production runs.
Adulteration through synthetic spike-ins or cheaper botanical analogues poses existential compliance and brand reputation risks. International buyers require rigorous identification protocols. MedGence pairs High-Performance Thin-Layer Chromatography (HPTLC) visual fingerprinting with quantitative High-Performance Liquid Chromatography (HPLC) and GC-MS profiling to identify true species provenance, guaranteeing freedom from adulterants.
Entry into top-tier consumer markets requires pristine toxicological clearance. Global procurement demands strict screening for heavy metals (Pb, As, Cd, Hg via ICP-MS), organophosphorus pesticide residues, polycyclic aromatic hydrocarbons (PAHs), residual solvents, aflatoxins, and microbial burdens. We integrate full-spectrum contaminant detection right from early discovery to eliminate border rejection risks.
Entrusting proprietary formulas or compound discovery programs to an overseas manufacturing partner demands ironclad legal confidentiality. Operating under bilateral Non-Disclosure Agreements (NDAs), we employ air-gapped data segregation and proprietary process shielding to ensure customer synthesis profiles, assay methodologies, and delivery vectors remain 100% confidential property.
Depleting wild botanical biodiversity creates severe supply volatility and consumer blowback. MedGence's screening platforms identify alternative agricultural cultivars and optimize cellular tissue cultures, replacing wild-harvested natural reserves with sustainably cultivated crops that boast identical or superior pharmacological profiles.
Combining geo-authentic botanical heritage (Dao Di) with automated continuous extraction, real-time Process Analytical Technology (PAT), and closed-loop green solvent recovery.
China's geographic diversity provides unmatched agro-climatic niches for botanical biosynthesis. Our proprietary botanical database maps seasonal metabolite variations across more than 400 native species. Sourcing directly from verified "Dao Di" (geo-authentic) producing origins maximizes active compound concentration at harvest, cutting raw biomass input requirements by 25–40%.
Legacy batch extraction suffers from thermal active degradation and low yield. Factory 4.0 facilities utilize continuous countercurrent extraction trains, automated low-temperature vacuum concentrators, and macroporous adsorption resin columns. This architecture maintains thermal integrity for sensitive molecules like polyphenols and terpenes while driving extraction yields up by 18–32%.
Our production lines integrate Near-Infrared (NIR) inline sensors and automated distributed control systems (DCS). Critical parameters—including solvent temperature, dynamic column pressure, pH, and instantaneous active concentrations—are monitored in real time, preventing batch drifts and ensuring high chemical reproducibility from lab bench to 10-ton industrial batches.
To meet strict European and North American environmental rules, our extraction platforms employ supercritical carbon dioxide (scCO₂) and automated closed-loop ethanol recycling systems. This completely eliminates toxic hydrocarbon residues like hexane, cuts VOC emissions to near zero, and yields clean, solvent-free botanical oils and high-purity crystalline isolates.
Technology transfer friction often stalls new natural product rollouts. MedGence pairs dedicated laboratory pilot testing units with commercial-scale extraction plants. Because the exact same chemical engineers guide pilot runs and commercial scale-up, our partners avoid scale-up yield collapse, speeding up time-to-market by 4 to 6 months.
| Evaluation Parameter | Traditional Herbal Processing | MedGence Factory 4.0 Platform | Strategic Advantage for Global Buyers |
|---|---|---|---|
| Active Density Targeting | Uncalibrated wild collection | GIS & seasonal chemometric mapping | Higher Yield / Lower Cost |
| Extraction Methodology | Atmospheric thermal decoction | Dynamic countercurrent & subcritical / scCO₂ | Zero Thermal Degradation |
| Process Analytics | Post-batch offline testing | Real-time inline NIR spectroscopy & DCS | Zero Out-of-Spec Batches |
| Solvent Integrity | Petroleum-based solvents (Hexane) | Food-grade aqueous ethanol / Supercritical CO₂ | Clean Label / EP Compliant |
| Analytical Method Validation | Basic TLC spot checking | Full ICH Q2(R1) HPLC/HPTLC fingerprinting | Audit-Ready for FDA/EMA |
A single integrated infrastructure supporting botanical projects across discovery, pharmacological qualification, analytical standardization, and commercial production.
Utilizing targeted bioassay-guided fractionation to isolate and identify single chemical entities from complex plant mixtures that drive therapeutic efficacy, balancing industrial extraction yields with ecological sustainability.
Quantifying seasonal and geographical variations across wild and cultivated crops. We map the exact harvest timelines and plant anatomies (leaves, bark, rhizomes) that provide the absolute highest active molecule concentration.
Developing and validating analytical testing protocols using HPLC, GC, LC-MS/MS, and HPTLC fingerprinting in compliance with ICH Q2(R1) standards, creating the core framework for global commercial QA/QC batch release.
Engineering the critical parameters of commercial manufacturing: raw material pre-treatment, solvent ratio, extraction temperature, resin chromatography purification, and crystallization parameters to secure maximum yield and purity.
Overcoming stability and formulation challenges such as poor aqueous solubility, high hygroscopicity, oxidation, and unpalatable taste to produce finished consumer products with confirmed bioactivity and shelf stability.
Establishing comprehensive safety profiles through GLP-compliant testing: oral acute toxicity (median lethal dose LD50), 90-day sub-chronic repeat-dose assays, and Ames/micronucleus genotoxicity testing required by international health regulators.
Conducting cellular and enzymatic functional screening to profile candidate molecules. High-value assays include free radical scavenging (DPPH, ORAC), inflammatory cytokine reduction (TNF-α, IL-6), and glucose uptake modulation.
Translational validation across rodent disease models for metabolic syndrome, neuroprotection, hepatic injury, and joint inflammation, establishing meaningful in vivo pharmacokinetic (PK) and pharmacodynamic (PD) correlation.
Conducting randomized, double-blind, placebo-controlled human trials for dietary supplement claim substantiation, alongside complete Phase I to Phase IV GCP clinical trial management supporting formal New Drug Applications (NDA).
Integrating modern phytochemical research with classical multi-herb synergy. We develop advanced complex formulations, establishing ingredient-to-ingredient compatibility, bioavailability optimization, and shelf-life stability profiles.
Pilot and commercial manufacturing of verified active botanical compounds in multiple formats: standardized extract powders, concentrated liquids, purified pastes, and volatile essential oils, backed by complete COAs and regulatory documentation.
Full turnkey contract development and commercial manufacturing of oral liquids, hard-shell capsules, softgels, micro-tablets, functional soluble powders, and effervescent granules produced in GMP-certified cleanroom suites.
Every stage culminates in a definitive, audit-ready data deliverable, giving procurement and technical directors total transparency and control over their pipeline milestones.
Phytochemical screening isolates candidate molecules while multi-origin agronomic evaluation pinpoints optimal plant provenance, harvest season, and anatomical yield.
Deliverable: Target Profile & Sourcing DossierDeveloping and validating custom HPLC, GC, and HPTLC fingerprint testing methods to establish rigorous raw material specifications and batch-to-batch chemical baselines.
Deliverable: Validated Methods & QC SpecsScaling up from bench to pilot plant: defining pre-treatment protocols, dynamic extraction ratios, resin filtration efficiency, and low-temperature drying parameters.
Deliverable: Master Process & Scalability ReportValidating biological mechanism of action across high-density in vitro cellular assays and in vivo disease animal models alongside complete GLP acute and sub-chronic toxicity testing.
Deliverable: Complete Preclinical Data PackageConducting human trial programs, ranging from focused clinical cohorts for nutraceutical claims substantiation to Phase I–IV clinical studies supporting regulatory drug filings.
Deliverable: GCP Clinical Study ReportIndustrial commercial batch manufacturing of active botanical ingredients or finished consumer dosage forms under strict GMP controls and airtight confidentiality safeguards.
Deliverable: Commercial Batches & Audit TrailA decade and a half of documented research delivered to leading international pharmaceutical corporations, research universities, and TCM hospital networks.
Years of Natural Medicine & Phytochemical R&D
Dedicated Research Staff & Analytical Scientists
Pharma Manufacturers & University Hospitals Served
Classic TCM Formulas Modernized with Evidence
Innovative Natural Medicines Developed
Hospital Preparation Official Registrations
Single-Herb Quality Standards & Processes Established
Entrusted Confidentiality & IP Protection Rate
Tailoring active compound screening, extraction chemistry, and dosage design to meet specific market regulations and consumer preferences worldwide.
High-potency standardized botanical extracts, customized polyphenolic blends, and human efficacy substantiation data designed for premium retail, health food, and e-commerce distribution. We solve solubility, stability, and taste challenges for functional beverages and tablets.
Targeted discovery of novel small-molecule active pharmaceutical ingredients (APIs). From bio-fractionation to complete preclinical profiling and Phase I–IV clinical validation, backed by our track record of developing 22 innovative natural medicines.
Bio-active plant molecules for cosmeceuticals, backed by documented in vitro skin-lightening (tyrosinase inhibition), anti-inflammatory, collagen synthesis stimulation, and cellular antioxidant safety data. Formulations are certified non-irritating and free of synthetic additives.
Supplied with full chromatographic fingerprint COAs, heavy metal testing, and residual solvent clearance:
Contract manufacturing in pharmaceutical-grade GMP facilities with flexible packaging solutions:
Our active ingredient screening, process engineering, and analytical standardization platforms support China's leading pharmaceutical brands and university hospitals.
Beijing Tongrentang Group
China Resources Sanjiu
Sunflower Pharmaceutical
Livzon Pharmaceutical
Dihon Pharmaceutical
Golden Throat Holdings
Yangtzi River Pharma
Beihai Gofar Chuanshan
Humanwell Healthcare
SCIMYTH Pharmaceutical
Shandong Hanfang
Luoxin Pharmaceutical
Zhongsheng Pharmaceutical
Brilliance & Abundance
Apeloa Pharmaceutical
Hunan Heng Chang Pharma
Baotou TCM
Kamp Medicine
Guangxi Santo Pharma
Hunan Kangshou Pharma
Jiangxi Juwang Pharma
Beijing Tcmages Pharma
Guizhou Ruihe Pharma
Anhui CR Jinchan Pharma
Kangmei Pharmaceutical
Hunan Tianjicaotang
Kingstone Unite Pharma
Shuguang Hospital (Shanghai)
Hunan Provincial TCM Hospital
1st Hospital Hunan Univ. TCM
2nd Xiangya Hospital
2nd Hospital Hunan Univ. TCM
Zhuzhou TCM OrthopedicsComprehensive answers addressing compliance, technology transfer, intellectual property protection, and analytical methodologies.
Select from our validated production-ready active ingredient modules and turnkey contract manufacturing packages for direct commercial procurement.
Full-scale commercial screening, fractionation, and bulk supply of verified plant-derived active compounds with defined chemical fingerprints.
Request Contract Quotation
GLP-compliant rodent animal models verifying functional endpoints, metabolic bioavailability, and acute and sub-chronic toxicological safety.
Review Animal Study Packages
Standardized cell-line testing quantifying anti-inflammatory, free-radical neutralization, skin-barrier restoration, and metabolic activity.
Initiate In Vitro Screening
Rigorous GCP-compliant clinical research programs generating robust human trial datasets to support regulatory filings and retail marketing claims.
Schedule Trial Consultation
Systematic chemometric profiling ensuring long-term supply stability and maximum active molecule concentrations at optimal procurement costs.
Order Agronomic Potency Study
Custom HPLC, HPTLC, and GC-MS analytical method development, fully validated for rapid commercial QC deployment and regulatory submissions.
Request Method Validation
High-throughput bioassay discovery targeting metabolic, immunological, and cardiovascular indications from verified botanical raw materials.
Explore Bioassay Pipeline
Comprehensive raw material qualification assessing botanical authentication, heavy metal clearance, active chemical purity, and stability.
Request Raw Material AuditsWhether you require bioassay screening, analytical method validation, animal pharmacology, or industrial commercial CDMO production, our 300+ scientists and process engineers are ready to scope your project specifications.
